Wellteq Digital Health Inc. Improves Nightly Sleep by 38 Minutes for Employees Across 13 Countries Study Published in US Medical Journal

Wellteq Digital Health Inc. Improves Nightly Sleep by 38 Minutes for Employees Across 13 Countries Study Published in US Medical Journal

  • WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF) has deployed the Company's sleep program in partnership with WTW (NASDAQ:WTW) to improve the sleep of employees within a large financial institution with operations in over 13 countries.

  • The Wellteq sleep program resulted in an improvement in sleep duration of an average of 38 minutes per night, as published in the Journal of Community Medicine & Public Health Care in the United States1.

  • McKinseyestimates that the cost of sleep deprivation towards burnout, exhaustion and depression is $680 billion per year in just five OECD countries, in the U.S. alone, 70M people are plagued with chronic insomnia2 (McKinsey, 2021).

  • Wellteq offers its corporate and insurance customers digital solutions across the four pillars of wellbeing - activity, nutrition, mental health and sleep. These evidence-based solutions are generating health outcomesand journal publications from the sub-clinical domain as the Company advances its digital solutions toward clinical settings.

  • Digital Health is a fast-growing market with projected CAGR of 25% to reach $660 billion by 20253 (Statistica, 2021).

WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF) (the "Company" or Wellteq"), which supplies digital health and wellness solutions to customers in 12 languages across 30 countries is pleased to announce the publication of "The Hidden Public Health Problem of Inadequate Sleep: Deploying Digital Mobile Technology to Improve Employee Sleep Hygiene in Asia" in the Journal of Community Medicine & Public Health Care published in the United States. The article was co-authored by WTW (NASDAQ:WTW) Regional Senior Consultant of Workplace Health and Wellbeing, Ms. Pheona Chua.

The results were drawn from across 13 nations, 8 enterprise markets and 529 participants and demonstrate a substantial and clinically meaningful improvement in nightly sleep duration achieved by 59% of employee participants. The weighted average sleep duration increase was 38 minutes of nightly additional sleep achieved. Based on an initial average sleep duration of 7 hours, this represents a 9% increase in weighted average nightly sleep duration. To view the study, visit:

https://www.heraldopenaccess.us/openaccess/the-hidden-public-health-problem-of-inadequate-sleep-deploying-digital-mobile-technology-to-improve-employee-sleep-hygiene-in-asia

Senior Consultant, Corporate Health & Wellbeing, Asia, WTW, Ms Pheona Chua shares "A benefit trends survey we conducted recently shows that two-thirds of employers in Asia Pacific are greatly concerned about employee stress, burnout and mental health issues - it is by far the leading concern they have for their workforce. One way to support employees is to help them have better quality and quantity of sleep. Multiple research has shown that sleep deprivation significantly affects our health, work performance, safety and overall wellbeing4. It is therefore beneficial that employers find ways to support employees in prioritising quality sleep in their daily lives so that they can perform their best at work. These do not need to be sophisticated. A simple sleep campaign can help employees to improve their sleeping habits. The focus here is to protect employees' wellbeing in whatever ways it takes".

Wellteq Medical Advisor and lead author Dr George Gellert stated, "The study findings demonstrate empirically and validate the ability of Wellteq's technology platform to effectively engage employees, and help them make the behavioral changes needed to reduce the contribution of inadequate sleep duration and hygiene to poor physical and mental health, and to inferior work performance and low job satisfaction. This sleep wellness capability5 will be integrated seamlessly with remote sleep monitoring and telemedicine capabilities the Company will release to market in 2022, enabling Wellteq to provide an unparalleled comprehensive sleep health solution to employers, providers and payers. In addition, the B2B and strategic partnering opportunities with existing manufacturers of sleep apnea and related sleep disorder technology will positively disrupt the current market, greatly benefiting employees and patients, and those who seek to maximize their health and well-being."

Wellteq CEO, Scott Montgomery states, "Sleep sits upstream to having the clarity and energy to make other lifestyle changes around mindset, then diet and exercise. It is hard for anyone to get their head right and to get their body right if they are not sleeping well. We are delighted to see Wellteq's sleep program and technological capabilities achieve these outcomes across large employee populations in multiple countries. In 2021, we began and in 2022 will continue a focus on expanding our existing mobile capabilities into telemedical health improvement and wellness across the full lifecycle of health care, health promotion and disease prevention. This will differentiate us in the corporate wellness marketplace and builds on our 2021 initiatives and momentum."

The impact of poor sleep hygiene on employee performance is costly for employers and insurers. Inadequate sleep and/or disrupted sleep are also one of the modifiable predictors of and contributors to chronic health problems among employees, generating significant avoidable costs for employers. Sleep impacts mental health, incidence of fatigue, burnout and exhaustion, and decreases workplace productivity by $1,300 to $3,000 per employee2. Work-from-home (WFH) has also created conditions that make the identification of employees at risk or suffering from these conditions much more difficult for management teams and colleagues, as well as far more challenging to support and remediate.

The future of sleep health and hygiene management is rapidly integrating digital tools and home-based solutions in a full lifecycle continuum with workplace efforts. Wellteq is positioned at the forefront of sleep disorder diagnosis, management and wellness coaching through its technology evolution and recent partnership with Monash University, a globally leading research and care delivery institution. Wellteq's ability to assess and achieve better sleep among large employee populations through a scalable digital platform is a key contributor to the Company's growth. Revenue from the global sleep market is projected to reach USD $137 billion by 2026, presenting a substantial and compelling opportunity for digital sleep health and wellness solution providers6.

References

  1. https://www.heraldopenaccess.us/openaccess/the-hidden-public-health-problem-of-inadequate-sleep-deploying-digital-mobile-technology-to-improve-employee-sleep-hygiene-in-asia
  2. https://www.mckinsey.com/industries/life-sciences/our-insights/sleep-on-it-addressing-the-sleep-loss-epidemic-through-technology
  3. https://www.statista.com/statistics/1092869/global-digital-health-market-size-forecast/
  4. https://www.wtwco.com/en-SG/Insights/2022/01/a-purposeful-employee-experience-is-driving-asia-pacific-employers-benefit-strategies
  5. https://www.businesswire.com/news/home/20211026005728/en/Wellteq-Digital-Health-Inc.-Partners-With-Top-Global-University-to-Commercialise-Sleep-Research
  6. https://www.arizton.com/market-reports/sleep-market-size-analysis

About WTW

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance. Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success-and provide perspective that moves you. Learn more at wtwco.com.

About WellteQ Digital Health Inc.

WellteQ Digital Health Inc. is a leading global provider of personalized digital health and wellness solutions across the continuum of care. To learn more, visit https://www.wellteq.co.

Download the Wellteq Corporate Presentation: https://wellteq.co/about/investors/

Wellteq Investor Contact:

Glen Akselrod
Bristol Investor Relations
E: glen@bristolir.com
T: (905) 326-1888

Cautionary Note Regarding Forward-Looking Statements:

This news release contains information or statements that constitute "forward-looking statements." Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of Wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of Wellteq. Forward-looking information is provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These statements should not be read as guarantees of future performance or results.

The forward-looking statements made in this news release are based on management's assumptions and analysis and other factors that may be drawn upon by management to form conclusions and make forecasts or projections, including management's experience and assessments of historical trends, current conditions and expected future developments. Although management believes that these assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory, legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand for Wellteq's products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and general market and economic conditions.

The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. Wellteq undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

The CSE has neither approved nor disapproved the contents of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113128

News Provided by Newsfile via QuoteMedia

WTEQ:CC
The Conversation (0)
wellteq Digital Health Inc. Announces Health Insurer Partner Extends the wellteq Digital Health Solution to All Australians

wellteq Digital Health Inc. Announces Health Insurer Partner Extends the wellteq Digital Health Solution to All Australians

  • nib (ASX: NHF) extends wellteq's digital health solutions to all Australians through the launch of GreenPass.

  • wellteq's digital health solution integrates its preferred partners, including Garmin (NASDAQ: GRMN) and other health provider partners, into the nib-customised digital wellness app to deliver several benefit pathways, from online health assessments, personalised content and rewards to expanding virtual care services.
  • Digital health is projected to be a USD 295.4 billion industry by 2028 with a compound annual growth rate (CAGR) of 15.1% from 2021 to 2028.
  • Asia-Pacific (APAC) is expected to register the fastest CAGR over the forecast period due to the rising usage of tablets, smartphones, and other mobile platforms across the region, which includes Australia, Japan, China, India, South Korea and Singapore.

WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF), (the "Company" or "wellteq"), is pleased to announce that one of Australia's largest health insurers, nib holdings limited (ASX: NHF), will now offer wellteq's digital health solution to all Australians, a population of over 25 million people.

nib Group (nib) is a trusted international health partner with over one million members across Australia. The launch of nib's GreenPass membership provides Australians with access to a range of exclusive health and wellness benefits without the need to take out a traditional health insurance product. The subscription-based service aims to empower more people to put their health and wellbeing first. Read more from nib's press release:

https://www.nib.com.au/media/2022/04/media-pages-nib-launches-unique-greenpass-health-membership

wellteq's digital health solution integrates its partners, including Garmin, Fitbit, Apple, and other health provider partners, into the nib-customised digital wellness app to help them deliver personalised content and healthy action nudges, gamification, rewards and more. nib's GreenPass membership enables non-private health insurance members to access several different benefit pathways, from personalised health plans, discounts on health and wellness services, rewards for reaching health goals through their well with nib app, an online skin check, fitness tracking and exclusive pricing with nib's network of trusted health professionals.

wellteq Chief Operating Officer, Jeames Gillett said: "wellteq has been working closely with nib for several years to evolve our shared ambition of providing personalised health and wellbeing at scale. We're incredibly excited to support nib in the launch of GreenPass as it extends access beyond private health insurance members to the wider Australian population. At a time when our health and wellbeing has been tested, access to GreenPass will provide individuals with an opportunity to have personalised support on their journey to better health."

Ed Close, nib Chief Executive Australian Residents Health Insurance said: "the GreenPass is a game-changer for the industry, designed to help more Aussies access the right tools, services and information they need to support their better health."

"By making membership as much about supporting good health as the treatment of sickness and injury we have an opportunity to play a bigger role in how we help more Australians to keep healthy and out of hospital,"

"With this in mind, we created nib GreenPass, which is intentionally created to empower people of all ages to better understand their health profile and offer health and wellness perks and services they can use every day to keep on top of their health."

This timely solution aligns with market projections1 that the global digital health industry will reach USD 295.4 billion by 2028, with a compound annual growth rate (CAGR) of 15.1% from 2021 to 2028. Asia-Pacific (APAC) is expected to register the fastest CAGR over the forecast period due to the rising usage of tablets, smartphones, and other mobile platforms across the region, which includes Australia, Japan, China, India, South Korea and Singapore.

Scott Montgomery, wellteq's Chief Executive Officer said: "when two companies missions align the synergies can create powerful things. nib's payer to partner strategy dovetails perfectly with wellteq's mission to coach healthier habits across the full continuum of healthcare. The manifestation of this synergy is GreenPass, a fantastic opportunity for anyone to try digital health tools at no cost and hopefully inspire them on a behaviour change journey that's good for them, good for nib and good for wellteq. The ideal win-win situation and another step towards proactive, equitable virtual care."

References

1. Digital Health Market Size, Share & Trends Analysis Report by Technology (Healthcare Analytics, mHealth), By Component (Software, Services), By Region, And Segment Forecasts, 2021 - 2028.

About WellteQ Digital Health Inc.

WellteQ Digital Health Inc. is a leading global provider of personalized digital health and wellness solutions across the continuum of care. To learn more, visit https://wellteq.co/

Download the wellteq Corporate Presentation:

https://wellteq.co/about/investors/

wellteq Investor Contact:
Glen Akselrod
Bristol Investor Relations
E: glen@bristolir.com
T: (905) 326-1888

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Wellteq Digital Health Inc. Announces Release of the IoMT HealthHub

Wellteq Digital Health Inc. Announces Release of the IoMT HealthHub

  • WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF) has released the Company's internet of medical things (IoMT) HealthHub into device integrations with Beta research partners for testing purposes.
  • The wellteq HealthHub is the result of an extensive internal development effort to produce an open standard and scalable IoMT platform for distributed virtual care deployments in enterprise health, clinic, pharmacy, and remote locations.
  • The wellteq HealthHub connects, manages, and monitors both standardized medical and non-medical devices for a completely integrated IoMT/IoT intelligent edge solution, allowing for control of any standardized commercial, industrial, residential, or medical smart device - an industry first and must-have for next generation virtual care deployments.
  • The initial market for the wellteq HealthHub will be B2B for both in-market and new-to-market virtual care solutions.
  • wellteq will soon offer its baseline B2B virtual care platform integrating the wellteq HealthHub, wellteq Clinical Vitals Wearable and the wellteq Virtual Care Coaching APP.
  • The IoMT market is projected to grow from $30.79 billion in 2021 to $187.60 billion in 2028 at a compound annual growth rate (CAGR) of 29.5%1. While annual digital health spending is projected to reach $660 billion by 20252.

WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF), (the "Company" or wellteq"), which supplies digital health and wellness solutions to customers in 12 languages across 32 countries is pleased to announce the Beta release of its new internet of medical things (IoMT) HealthHub, targeting commercial release later this year.

Based on a survey2of physicians in the United States who serve predominantly Medicare fee-for-service (FFS) and Medicare Advantage (MA) patients, McKinsey estimates that up to $265 billion (about $820 per person in the US) worth of care services - which represents up to 25% of the total cost of care - for Medicare FFS and MA beneficiaries could shift from traditional facilities to the home by 2025, without a reduction in quality or access.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Wellteq Digital Health Inc. Launches North America Growth Division

Wellteq Digital Health Inc. Launches North America Growth Division

  • wellteq has appointed Mr Andrew Hvzid as Head of Growth, North America.
  • Based out of Toronto, Canada, Andrew Hvzid will be instrumental in accelerating wellteq's market share within the Corporate Wellness, Insurance and Health Provider sectors of Canada and North America, as well as leveraging the Company's existing distribution partners WTW (NASDAQ: WTW) and Garmin (NASDAQ: GRMN) in these new territories.
  • Mr Hvzid brings over a decade of executive experience in building strategic partnerships, identifying revenue-generating opportunities and optimising resources to propel growth across the health, fitness and education sectors.
  • Digital health is projected to be a USD 295.4 billion industry by 2028 with a compound annual growth rate (CAGR) of 15.1% from 2021 to 2028.
  • In 2020, North America accounted for the largest market share of the digital health industry at 38.77% and is expected to experience a steady CAGR over the forecast period.

WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF), (the "Company" or "wellteq"), is pleased to announce its strategic expansion into North America through the appointment of Mr. Andrew Hvizd as Head of Growth (NA) for the region. The Company recognises the importance of acquiring, developing and retaining top talent to drive commercial growth in the diverse and localised areas of the global digital health market - an industry that is projected to be valued at USD 295.4 billion by 2028[1].

As Head of Growth (NA), Andrew Hvizd will lead wellteq's go-to-market strategy in Canada and North America, enabling the Company's continued market expansion in the region. He will be instrumental in acquiring strategic partnerships and accelerating sustainable revenue growth, as well as leveraging wellteq's existing distribution partners, including WTW (NASDAQ: WTW) and Garmin (NASDAQ: GRMN), in these new territories.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Wellteq Chairman Appointed to the Order of Canada for Leadership in Digital Health

Wellteq Chairman Appointed to the Order of Canada for Leadership in Digital Health

  • Dr. Peter W. Vaughan, CM, CD, MA, MD, MPH, ICD.D, Chairman of the Board of Directors at WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF) has been appointed to the Order of Canada.
  • Recognised by the Governor General of Canada "for his contributions to Canada's health care system, and for his pioneering leadership in the establishment and advancement of digital health"
  • Digital Health market size projected at nearly 25% CAGR from 2019 to become a US$660 billion industry by 2025 (Statistica Research - July 2021)

WellteQ Digital Health Inc. (CSE: WTEQ) (OTCBB: WTEQF), (the "Company" or "Wellteq"), which supplies digital health and wellness solutions to customers in 12 languages across 30 countries is pleased to announce the Company's Chairman, Dr Peter Vaughan, has been appointed to the Order of Canada by the Governor General of Canada.

The Governor General cited the appointment of Dr Vaughan "for his contributions to Canada's health care system, and for his pioneering leadership in the establishment and advancement of digital health".

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
continuum global solutions

Wellteq Digital Health Inc. Upcoming Investor Events

  • WellteQ Digital Health Inc. (CSE: WTEQ / OTCQB: WTEQF) is pleased to announce two upcoming investor events.
  • Wellteq will be hosting an Investor Webcast on November 10 th , 2021.
  • Wellteq will also be participating in the 3 rd Annual Canaccord Genuity Health & Wellness Conference on November 16 th , 2021

WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF) , (the "Company" or "Wellteq"), which supplies digital health and wellness solutions to customers in 12 languages across 30 countries is pleased to announce two upcoming investor events.

Wellteq Investor Webcast on Wednesday, November 10th, 2021

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 NASDAQ Biotech Stocks of 2024

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has traded at three-year highs in the first half of 2024 in response to looming interest rate cuts, breakthrough innovations and increased deals in the space.

After dropping to a low of 3,637.05 in October 2023, the index climbed to start 2024 at 4,457.02. It did hit a bump in the road early in Q2 when it plunged to 4,056.3 in April, but it quickly recovered and has since tracked even higher, reaching 4,634.21 on June 24. But while the current economic environment means the biotech sector may have a complex road ahead, robust growth could be in store in the future.

According to a recent report from Precedence Research, the global biotech market is expected to grow at a compound annual growth rate of 11.8 percent from now to 2033, reaching a valuation of US$4.25 trillion.

Keep reading...Show less
Radiopharm Theranostics

First Patient Dosed with PD-L1 Nanobody in Phase 1 Therapeutic Non-Small Cell Lung Cancer Trial

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce the therapeutic dosing of the first patient in its Phase 1 clinical trial of RAD 204, a proprietary nanobody which targets Programmed death-ligand 1 (PD-L1)-positive expression in Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer.

Keep reading...Show less
Test tubes.

Can AI Help Detect Cancer? Data Analysis Could Open Up Possibilities for Healthcare Industry

Artificial intelligence (AI) has emerged as a valuable tool for solving complex societal issues, and although it's a new industry, its impact is already being felt in key areas of the life science sector.

AI models in healthcare are quickly advancing beyond basic tasks like medical transcription and administrative streamlining; many systems can now effectively analyze extensive genetic data.

By harnessing AI models' ability to identify patterns and make predictions, medical professionals can institute more effective, personalized treatments and develop precision tests to catch diseases earlier.

Keep reading...Show less
Biotech therapy capsule containing DNA strand surrounded by cells.

Top 3 Canadian Biotech Stocks of 2024

Biotech is a dynamic industry that is driving scientific advancements and innovation in healthcare.

According to Grandview Research, the global biotech market was worth US$1.55 trillion in 2023, and the firm expects it to grow at a CAGR of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion.

In Canada, the biotech industry is home to companies pursuing cutting-edge therapies and medical technologies, and the Investing News Network has identified the top three biotech stocks based on their year-on-year gains.

Keep reading...Show less
Radiopharm Theranostics

Investor Webinar – 3pm AEST Tuesday 2 July

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that CEO and Managing Director Riccardo Canevari and Executive Chairman Paul Hopper will conduct an investor webinar to provide an update following announcement of the Company’s $70 million capital raising.

When: 3pm AEST, Tuesday 2 July 2024

Keep reading...Show less
Researcher in medical lab looking at sample with microscope.

Oncology Stocks: 8 Biggest NASDAQ Companies in 2024

The wide-ranging oncology market covers every area of cancer care, from diagnosis to treatment.

Coming in only after cardiovascular disease, cancer is the second leading cause of death worldwide; unsurprisingly, oncology is one of the biggest sectors in the life science space. With that in mind, biotechnology and pharmaceutical companies alike are working to develop best-in-class therapeutics for the treatment of various cancers, including lung, breast and prostate cancer.

At this point, their work is far from finished — Fortune Business Insights projects that the global oncology market will increase at a compound annual growth rate of 11.3 percent to reach US$518.25 billion in 2032.

As the global oncology market grows, investors who want exposure to companies working to treat cancer should consider taking a look at biotech and pharma companies with a focus on oncology drugs and testing.

Keep reading...Show less

Latest Press Releases

Related News

×